The Reviv Peptides Research Team is a collective of science writers and researchers dedicated to producing evidence-based, peer-reviewed-grade content about research peptides. Our work focuses on molecular mechanisms, receptor pharmacology, and preclinical data — including GLP-1/GIP/glucagon incretin biology, growth hormone axis peptides (GHRH analogs and ghrelin-receptor secretagogues), mitochondrial-derived peptides (MOTS-c, SS-31), tissue-repair peptides (BPC-157, TB-500, GHK-Cu), and nootropic peptides (Semax, Selank). All content is written in a strict preclinical/laboratory context; none of our editorial material is intended as medical advice. Every guide is reviewed for scientific accuracy against published peer-reviewed literature.
A research-focused guide to NAD+ (nicotinamide adenine dinucleotide): its dual roles in redox metabolism and cellular signalling, age-related depletion, sirtuin and PARP activation, neurological applications, and sourcing considerations for laboratory research.
A comprehensive research guide to GHK-Cu (glycyl-L-histidyl-L-lysine copper complex): its molecular structure, extraordinary gene expression modulation across 4,000+ genes, wound healing research, and applications in anti-aging and longevity science.
A detailed research guide to TB-500 (Thymosin Beta-4 fragment): its role in actin regulation, studied mechanisms in wound healing, musculoskeletal repair and cardiac protection, and why it's frequently combined with BPC-157 in preclinical research.
A research-focused comparison of semaglutide (GLP-1 agonist) and tirzepatide (GIP/GLP-1 dual agonist): mechanisms of action, structural differences, key clinical trial data, and considerations for metabolic research design.
A comprehensive research guide to BPC-157: its molecular structure, studied mechanisms including tendon healing, gut protection, and neurological effects, and what researchers need to know about sourcing and purity.
